IVAX VERAPAMIL ER SALES ARE $145.9 MIL. IN 1993, OR 29% OF PHARMACEUTICAL NET REVENUES OF $500.5 MIL.; VALUE HEALTH 12-MONTH Rx DRUG REVENUES ARE $364.7 MIL.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".